vismodegib (Compound)

Synonyms:Vismodegib, 879085-55-9, GDC-0449, Erivedge, 2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide, Vismodegib (GDC-0449), HhAntag691, GDC0449, GDC 0449, NSC-747691, NSC-755986, 2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-(methylsulfonyl)benzamide, CHEMBL473417, CHEBI:66903, 2-chloro-N-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide, 25X868M3DS, NSC755986, 2-chloro-n-[4-chloro-3-(pyridin-2-yl)phenyl]-4-methanesulfonylbenzamide, 2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide, 2-chloro-n-(4-chloro-3-(2-pyridinyl)phenyl)-4-(methylsulfonyl)benzamide, 2-chloro-N-(4-chloro-3-pyridin-2-yl-phenyl)-4-methanesulfonyl-benzamide, Benzamide, 2-chloro-N-(4-chloro-3-(2-pyridinyl)phenyl)-4-(methylsulfonyl)-, 2-Chloranyl-~{n}-(4-Chloranyl-3-Pyridin-2-Yl-Phenyl)-4-Methylsulfonyl-Benzamide, GDC-0449 (Vismodegib), Erivedge (TN), Vismodegib [USAN], Vismodegib [USAN:INN], NSC 747691, vismodegibum, UNII-25X868M3DS, HSDB 8130, R 3616, VIS, NSC747691, Hh-Antag691, HhAntag 691, Vismodegib, free base, RG 3616, RG-3616, methanesulfonylbenzamide, VISMODEGIB [MI], VISMODEGIB [INN], Vismodegib (USAN/INN), VISMODEGIB [VANDF], Vismodegib; GDC-0449, R-3616, VISMODEGIB [WHO-DD], GDC-0449 - Selumetinib, MLS006012035, SCHEMBL302587, GTPL6975, VISMODEGIB [ORANGE BOOK], CUR-691, DTXSID40236689, GDC-449, BCPP000223, HMS3604K16, HMS3654E17, BCP01715, EX-A2178, BDBM50249522, MFCD12407408, NSC755809, s1082, GDC-0449,Vismodegib, HhAntag691, 2-Chloro-N-(4-chloro-3-(pyridin-2-yl)-phenyl)-4-(methylsulfonyl)benzamide, AKOS015966534, BCP9000713, CCG-264811, CS-0255, DB08828, NSC-755809, PB15086, NCGC00242497-01, NCGC00242497-02, NCGC00242497-06, NCGC00242497-12, AC-26969, AS-14066, HY-10440, SMR004703564, FT-0675833, SW218087-2, EC-000.2333, D09992, V-4050, AB01565813_02, EN300-7413185, SR-01000941574, 2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-, J-509076, Q2070286, SR-01000941574-1, 2-Chloro-N-(4-chloro-3-(2-pyridl)phenyl)-4-(methylsulfonyl)benzamide, 2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methyl sulfonyl)benzamide, 2-chloro-N~1~-[4-chloro-3-(2-pyridyl)phenyl]-4-(methylsulfonyl)benzamide, 2-CHLORO-N-(4-CHLORO-3-PYRIDIN-2-YL)PHENYL)-4-(METHYLSULFONYL)BENZAMIDE, 2-CHLORO-N-[4-CHLORO-3-(2-PYRIDINYL)PHENYL]-4-(METHYLSULFONYL)-BENZAMIDE
Pubchem:PUBCHEM:24776445
Id:f1bfe06d-6336-5fb6-a0a3-0e6f8b72463f
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View vismodegib's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for vismodegib.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with vismodegib.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.